organ-specific cardiac antibodies were more common in patients with dilated cardiomyopathy and in those with fewer symptoms ( 8 of 15 in new york heart association functional class i versus 9 of 50 in classes ii to iv , p less than 0.01 ) and more recent ( less than 2 years ) onset of disease ( 9 of 19 versus 8 of 46 , p less than 0.02 ) .
C0018787
cardiac
C0007193
dilated cardiomyopathy